Peter Wipf
81Patents
9h-index
98Co-inventors
81Inventor score
Filing activity: Jul 30, 1996 → Dec 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5952294A | Peptidyl prodrugs and methods of making and using the same | Human Necessities | 34 | Expired |
| US7166725B2 | Benzo[d]isoxazol-3-ol DAAO inhibitors | Human Necessities | 32 | Expired |
| US5859247A | Fluorous reaction and separation systems | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6156896A | Fluorous reaction and separation systems | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7528174B2 | Selective targeting agents for mitochondria | Human Necessities | 19 | Active |
| US8288551B2 | Targeted nitroxide agents | Chemistry; Metallurgy | 19 | Active |
| US7718603B1 | Selective targeting agents for mitochondria | Chemistry; Metallurgy | 18 | Active |
| US5700821A | Phosphatase inhibitors and methods of use thereof | Human Necessities | 13 | Expired |
| US9675446B2 | Prosthetic implant for medialization thyroplasty | Human Necessities | 9 | Active |
| US5925660A | Phosphatase inhibitors and methods of use thereof | Human Necessities | 8 | Expired |
| US9072760B2 | TLR4 inhibitors for the treatment of human infectious and inflammatory disorders | Human Necessities | 8 | Active |
| US5856506A | Phosphatase inhibitors and methods of use thereof | Human Necessities | 6 | Expired |
| US6040323A | Phosphatase inhibitors and methods of use thereof | Human Necessities | 5 | Expired |
| US8609850B2 | Targeted nitroxide agents | Chemistry; Metallurgy | 5 | Active |
| US9006186B2 | Selective targeting agents for mitochondria | Chemistry; Metallurgy | 5 | Active |
| US6673539B1 | Fluorous tagging compounds and methods of use thereof | Chemistry; Metallurgy | 5 | Expired |
| US6803475B2 | Fluorous tagging compounds and methods of use thereof | Chemistry; Metallurgy | 4 | Expired |
| US7446124B2 | Wortmannin analogs and methods of using same in combination with chemotherapeutic agents | Chemistry; Metallurgy | 3 | Active |
| US10172795B2 | Formulations and carrier systems including compound interactive domains | Human Necessities | 3 | Active |
| US9200035B2 | Bifunctional compounds | Chemistry; Metallurgy | 3 | Active |
| US9532999B2 | TLR4 inhibitors for the treatment of human infectious and inflammatory disorders | Human Necessities | 2 | Active |
| US11214560B2 | Modulators of P97 AAA ATPase activity | Chemistry; Metallurgy | 2 | Active |
| US8487079B2 | Use of mitochondria-targeted electron scavengers as anti-inflammatory agents | Human Necessities | 2 | Active |
| US9217000B2 | Targeted nitroxide agents | Chemistry; Metallurgy | 2 | Active |
| US8937086B2 | Compounds for the treatment of pathologies associated with aging and degenerative disorders | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.